Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
HIV-1 latency reversal agent boosting is not limited by opioid useTyler Lilie, Jennifer Bouzy, Archana Asundi, et al.
The Journal of Infectious Diseases|February 23, 2024
Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV InfectionRiley M F Pihl, Erika L Smith-Mahoney, Alex Olson, et al.
JCI Insight|October 29, 2024
HIV-1 latency reversal agent boosting is not limited by opioid useTyler Lilie, Jennifer Bouzy, Archana Asundi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2026
Alterations to the bronchial gene-expression effects of tobacco smoking in people living with HIVMinyi Lee, Alex Olson, Richard T Pickering, et al.
Plos Pathogens|December 28, 2021
Intragenic proviral elements support transcription of defective HIV-1 provirusesJeffrey Kuniholm, Elise Armstrong, Brandy Bernabe, et al.
Nature Communications|December 8, 2020
Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Nature Communications|November 18, 2020
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cellsDeli Huang, Jenny Tuyet Tran, Alex Olson, et al.
Pageof 3